Diethyl {[5-(3-fluorophenyl)pyridin-2-yl]methyl}phosphonate: A Critical Intermediate in Pharmaceutical Synthesis

Unlock the potential of advanced pharmaceutical development with Diethyl {[5-(3-fluorophenyl)pyridin-2-yl]methyl}phosphonate, a high-purity compound essential for synthesizing life-saving medications like Vorapaxar. Explore its critical role and specifications.

Get a Quote & Sample

Benefits of Using This Intermediate

Enhanced Synthesis Efficiency

Leverage this high-quality intermediate to optimize your synthesis processes, potentially reducing reaction steps and improving overall yields for complex molecules like Vorapaxar, a key aspect of efficient pharmaceutical intermediate manufacturing.

Guaranteed Product Quality

Our commitment to quality assurance ensures that every batch of Diethyl {[5-(3-fluorophenyl)pyridin-2-yl]methyl}phosphonate meets strict specifications, providing a reliable foundation for your API production and supporting robust drug discovery.

Reliable Supply Chain Partner

As a dedicated supplier in China, we offer consistent availability and timely delivery of this critical intermediate, supporting the continuous operation of your manufacturing processes and ensuring a stable supply chain for your pharmaceutical needs.

Key Applications

Pharmaceutical Synthesis

A primary application is in the synthesis of Vorapaxar and its sulfate salt, critical for antiplatelet therapy and the prevention of thrombotic cardiovascular events, underscoring its role in cardiovascular drug synthesis.

Fine Chemical Manufacturing

Serves as a versatile building block in the fine chemical industry for creating complex organic molecules with specific functionalities, essential for advanced chemical manufacturing.

Drug Discovery Research

Utilized in research and development for creating novel compounds and exploring new therapeutic targets, contributing to the broader landscape of drug discovery and development.

API Intermediate Sourcing

An essential component for companies seeking reliable sourcing of Active Pharmaceutical Ingredient (API) intermediates, ensuring the quality and consistency required for regulatory compliance and market readiness.